Pooled prevalence estimates 25.2 and 20.5 percent for clinically elevated depression and anxiety symptoms, respectively
One in Four Survivors of COVID-19 Have Symptoms at Six Months
Fatigue, shortness of breath, and depression are the most common long COVID-19 symptoms
Anxiety, Depressive Disorders Increased August 2020 to February 2021
In addition, increase seen in percentage of adults reporting they needed but did not receive mental health counseling or therapy
Decline in Exercise Linked to Higher Depression During Pandemic
Among college students, disruption to physical activity a leading risk factor for depression during the COVID-19 pandemic
Over Half Have Symptoms of Major Depressive Disorder After COVID-19
Presence of headache and greater overall severity linked to increased odds of moderate or greater depression symptoms
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
Patients With RA Have Increased Anxiety During Pandemic
Anxiety during pandemic correlated with Health Assessment Questionnaire, biologic drug use, and previous anxiety point
Anxiety, Depression Remain High Following Initial Lockdown
Depression more likely among men; anxiety more likely for women
Primary Care-Recorded Mental Illness Decreased During COVID-19
Reductions seen in incidence of primary care-recorded depression, anxiety disorders, first antidepressant prescribing in United Kingdom
Symptoms Persist in Many Discharged COVID-19 Patients
Most common symptoms at six months were fatigue or muscle weakness, sleep difficulties, anxiety or depression